These side effects have prompted numerous individuals to file lawsuits, arguing that Novo Nordisk failed to adequately warn users of these potential risks
Eligibility to File a GLP-1 Lawsuit in Louisiana You may qualify for a GLP-1 lawsuit if you were prescribed a GLP-1 drug and suffered serious health complications as a result
Usage of GLP-1s is growing: posting 12.4% in fall 2025, up from 5.8% in early 2024, according to Gallup
These foods not only help in maintaining muscle mass but also aid in regulating appetite and glucose metabolism, indirectly supporting GLP-1 function
Lilly currently leads much of the obesity drug market with Zepbound, while rival Novo Nordisk dominates with Ozempic and Wegovy
Here's what actually matters: gastric emptying delay and satiety signaling begin within 24 hours post-injection, peak at 812 hours, and taper gradually over 4872 hours before the next dose cycle begins